1 / 6

Using QALYs to Evaluate Chronic Sequelae: The Case of Reactive Arthritis

Using QALYs to Evaluate Chronic Sequelae: The Case of Reactive Arthritis. David Zorn CFSAN-FDA David.Zorn@fda.hhs.gov. Background on Valuing Chronic Sequelae. Buzby, Roberts, Lin, and MacDonald, 1996 Hemolitic Uremic Syndrome (HUS) Listeriosis Zorn and Klontz, 1998

zed
Download Presentation

Using QALYs to Evaluate Chronic Sequelae: The Case of Reactive Arthritis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Using QALYs to Evaluate Chronic Sequelae: The Case of Reactive Arthritis David Zorn CFSAN-FDA David.Zorn@fda.hhs.gov

  2. Background on Valuing Chronic Sequelae • Buzby, Roberts, Lin, and MacDonald, 1996 • Hemolitic Uremic Syndrome (HUS) • Listeriosis • Zorn and Klontz, 1998 • Reactive Arthritis (ReA) • Scharff and Jessup, 2007 • ReA • Apologies to others

  3. Regulatory Analyses including Valuations of Chronic Sequelae • Food Safety & Inspection Service Meat & Poultry HACCP Rule (unpublished 1996) • FDA Juice Labeling and HACCP Rules (1998, 2001) • FDA Egg Refrigeration & Labeling Rule (1999, 2000) • FDA Egg Production Rule (2004)

  4. Previous Illustration

  5. Simple Method for Valuation of Chronic Sequelae • Adaptation of FDA’s method for acute illness • Monetized QALYs + Medical Costs • Duration of symptoms is lengthened (QALD loss/symptom) x (days) x ($ of QALD) + Medical Costs

  6. QALY Valuation of Reactive Arthritis

More Related